OpenURL Connection Search

Select item for more details and to access through your institution.

C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12058-y
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Shimada, Noritomo;
- Kawata, Kazuhito
Publication type:
Article
Lenvatinib for Hepatocellular Carcinoma: A Literature Review.
Published in:
Pharmaceuticals (14248247), 2021, v. 14, n. 1, p. 36, doi. 10.3390/ph14010036
By:
- Hatanaka, Takeshi;
- Naganuma, Atsushi;
- Kakizaki, Satoru
Publication type:
Article
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
Published in:
Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2042
By:
- Ohama, Hideko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Hatanaka, Takeshi;
- Tani, Joji;
- Takaguchi, Koichi;
- Atsukawa, Masanori;
- Itobayashi, Ei;
- Nishimura, Takashi;
- Tsuji, Kunihiko;
- Tajiri, Kazuto;
- Ishikawa, Toru;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Fukunishi, Shinya;
- Ogawa, Chikara;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience.
Published in:
Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1464
By:
- Atsushi Hiraoka;
- Takashi Kumada;
- Toshifumi Tada;
- Masashi Hirooka;
- Kazuya Kariyama;
- Joji Tani;
- Masanori Atsukawa;
- Koichi Takaguchi;
- Ei Itobayashi;
- Shinya Fukunishi;
- Kunihiko Tsuji;
- Toru Ishikawa;
- Kazuto Tajiri;
- Hironori Ochi;
- Satoshi Yasuda;
- Hidenori Toyoda;
- Chikara Ogawa;
- Takashi Nishimura;
- Takeshi Hatanaka;
- Hideko Ohama
Publication type:
Article
Editorial: Predictive Factors and Survival Outcome of Conversion Therapy for Unresectable Hepatocellular Carcinoma Patients Receiving Atezolizumab and Bevacizumab: Comparative Analysis of Conversion, Partial Response and Complete Response Patients. Authors' Reply
Published in:
Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1469, doi. 10.1111/apt.18319
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Kumada, Takashi
Publication type:
Article
Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.
Published in:
Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishikawa, Hiroki;
- Nishimura, Takashi;
- Kawata, Kazuhito;
- Kosaka, Hisashi
Publication type:
Article
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.
Published in:
Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Nishikawa, Hiroki;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Koshiyama, Yuichi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Kawata, Kazuhito
Publication type:
Article
Improved survival of viral hepatocellular carcinoma but not non‐viral hepatocellular carcinoma from 2000 to 2020: A multi‐centre cohort study of 6007 patients from high‐volume academic centres in Japan.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 694, doi. 10.1111/apt.17088
By:
- Toyoda, Hidenori;
- Kariyama, Kazuya;
- Hiraoka, Atsushi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Hatanaka, Takeshi;
- Naganuma, Atsushi;
- Yasuda, Satoshi;
- Nouso, Kazuhiro;
- Kakizaki, Satoru;
- Kumada, Takashi;
- Innes, Hamish;
- Johnson, Philip J.
Publication type:
Article
Successful Treatment of Metastatic Gallbladder Carcinoma with a High Tumor Mutational Burden Using Pembrolizumab.
Published in:
Internal Medicine, 2023, v. 62, n. 21, p. 3151, doi. 10.2169/internalmedicine.1610-23
By:
- Sanae Uehara;
- Atsushi Naganuma;
- Nozomi Furuichi;
- Ai Furusawa;
- Takuya Kaburagi;
- Hiroaki Naruse;
- Shota Tomaru;
- Nozomi Sano;
- Yuhei Suzuki;
- Tomoyuki Masuda;
- Takashi Hoshino;
- Hidetoshi Yasuoka;
- Yuko Tanaka;
- Shuichi Saito;
- Takeshi Hatanaka;
- Satoru Kakizaki
Publication type:
Article
Chronic Infection with Hepatitis C Virus Subtype 1g in a Japanese Patient Successfully Treated with Glecaprevir/Pibrentasvir.
Published in:
Internal Medicine, 2022, v. 61, n. 10, p. 1537, doi. 10.2169/internalmedicine.8673-21
By:
- Takeshi Hatanaka;
- Satoru Kakizaki;
- Takuya Kaburagi;
- Naoto Saito;
- Sachi Nakano;
- Yoichi Hazama;
- Sachiko Yoshida;
- Yoko Hachisu;
- Yoshiki Tanaka;
- Teruo Yoshinaga;
- Kenji Kashiwabara;
- Atsushi Naganuma;
- Yuichi Yamazaki;
- Toshio Uraoka;
- Shigeo Nagashima;
- Masaharu Takahashi;
- Tsutomu Nishizawa;
- Kazumoto Murata;
- Hiroaki Okamoto
Publication type:
Article
Follow-up after Direct-acting Antiviral Treatment for Chronic Hepatitis C Virus Infection: Most Patients Are Followed Appropriately.
Published in:
Internal Medicine, 2021, v. 60, n. 19, p. 3061, doi. 10.2169/internalmedicine.6591-20
By:
- Hiroki Tojima;
- Satoru Kakizaki;
- Satoshi Takakusagi;
- Takashi Hoshino;
- Atsushi Naganuma;
- Tamon Nagashima;
- Masashi Namikawa;
- Takashi Ueno;
- Yasushi Shimada;
- Takeshi Hatanaka;
- Daichi Takizawa;
- Hirotaka Arai;
- Ken Sato;
- Hitoshi Takagi;
- Toshio Uraoka
Publication type:
Article
Efficacy of Zinc Acetate Treatment for Patients with Decompensated Liver Cirrhosis Complicated by Hypozincemia.
Published in:
Biological Trace Element Research, 2022, v. 200, n. 2, p. 497, doi. 10.1007/s12011-021-02675-5
By:
- Horiguchi, Suguru;
- Naganuma, Atsushi;
- Tateyama, Yumeo;
- Suzuki, Yuhei;
- Hoshino, Takashi;
- Saito, Naoto;
- Hatanaka, Takeshi;
- Takakusagi, Satoshi;
- Kosone, Takashi;
- Takagi, Hitoshi;
- Uraoka, Toshio;
- Kakizaki, Satoru
Publication type:
Article
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
Published in:
Hepatology Research, 2024, v. 54, n. 4, p. 382, doi. 10.1111/hepr.13991
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Yokohama, Keisuke;
- Nishikawa, Hiroki
Publication type:
Article
Geriatric nutritional risk index as an easy‐to‐use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Published in:
Hepatology Research, 2023, v. 53, n. 10, p. 1031, doi. 10.1111/hepr.13934
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Association of proton pump inhibitor and antibiotic use with the clinical outcomes of hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: A multicenter analysis.
Published in:
Hepatology Research, 2023, v. 53, n. 8, p. 737, doi. 10.1111/hepr.13905
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice.
Published in:
Hepatology Research, 2022, v. 52, n. 9, p. 773, doi. 10.1111/hepr.13797
By:
- Tanaka, Takaaki;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis.
Published in:
Hepatology Research, 2022, v. 52, n. 5, p. 462, doi. 10.1111/hepr.13748
By:
- Hatanaka, Takeshi;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis.
Published in:
Hepatology Research, 2022, v. 52, n. 3, p. 308, doi. 10.1111/hepr.13734
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression.
Published in:
Hepatology Research, 2021, v. 51, n. 8, p. 880, doi. 10.1111/hepr.13644
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Hatanaka, Takeshi;
- Tada, Toshifumi;
- Kariyama, Kazuya;
- Tani, Joji;
- Fukunishi, Shinya;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Kawata, Kazuhito;
- Yasuda, Satoshi;
- Toyoda, Hidenori
Publication type:
Article
Real‐world efficacy and safety of 12‐week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection.
Published in:
Hepatology Research, 2021, v. 51, n. 1, p. 51, doi. 10.1111/hepr.13576
By:
- Takaoka, Yoshinari;
- Miura, Kouichi;
- Morimoto, Naoki;
- Ikegami, Tadashi;
- Kakizaki, Satoru;
- Sato, Ken;
- Ueno, Takashi;
- Naganuma, Atsushi;
- Kosone, Takashi;
- Arai, Hirotaka;
- Hatanaka, Takeshi;
- Tahara, Toshiyuki;
- Tano, Shigeo;
- Ohtake, Takaaki;
- Murohisa, Toshimitsu;
- Namikawa, Masashi;
- Asano, Takeharu;
- Kamoshida, Toshiro;
- Horiuchi, Katsuhiko;
- Nihei, Takeshi
Publication type:
Article
Favorable outcome of retreatment by direct‐acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failure.
Published in:
Hepatology Research, 2020, v. 50, n. 3, p. 303, doi. 10.1111/hepr.13462
By:
- Tojima, Hiroki;
- Kakizaki, Satoru;
- Takakusagi, Satoshi;
- Hoshino, Takashi;
- Naganuma, Atsushi;
- Nagashima, Tamon;
- Namikawa, Masashi;
- Ueno, Takashi;
- Shimada, Yasushi;
- Hatanaka, Takeshi;
- Takizawa, Daichi;
- Arai, Hirotaka;
- Sato, Ken;
- Takagi, Hitoshi;
- Uraoka, Toshio
Publication type:
Article
Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study.
Published in:
Hepatology Research, 2020, v. 50, n. 3, p. 382, doi. 10.1111/hepr.13460
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Nagashima, Tamon;
- Namikawa, Masashi;
- Tojima, Hiroki;
- Shimada, Yasushi;
- Takizawa, Daichi;
- Naganuma, Atsushi;
- Arai, Hirotaka;
- Sato, Ken;
- Harimoto, Norifumi;
- Shirabe, Ken;
- Uraoka, Toshio
Publication type:
Article
Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin.
Published in:
Hepatology Research, 2018, v. 48, n. 3, p. E347, doi. 10.1111/hepr.12971
By:
- Sato, Ken;
- Naganuma, Atsushi;
- Nagashima, Tamon;
- Hoshino, Takashi;
- Uehara, Daisuke;
- Arai, Yousuke;
- Horiuchi, Katsuhiko;
- Yuasa, Kazuhisa;
- Takayama, Hisashi;
- Arai, Hirotaka;
- Hatanaka, Takeshi;
- Ohyama, Tatsuya;
- Tahara, Hiroki;
- Sohara, Naondo;
- Kobayashi, Takeshi;
- Horiguchi, Norio;
- Yamazaki, Yuichi;
- Kakizaki, Satoru;
- Kusano, Motoyasu;
- Yamada, Masanobu
Publication type:
Article
Factors predicting overall response and overall survival in hepatocellular carcinoma patients undergoing balloon‐occluded transcatheter arterial chemoembolization: A retrospective cohort study.
Published in:
Hepatology Research, 2018, v. 48, n. 2, p. 165, doi. 10.1111/hepr.12912
By:
- Hatanaka, Takeshi;
- Arai, Hirotaka;
- Shibasaki, Mitsuhiko;
- Tojima, Hiroki;
- Takizawa, Daichi;
- Toyoda, Mitsuo;
- Takayama, Hisashi;
- Abe, Takehiko;
- Sato, Ken;
- Kakizaki, Satoru;
- Yamada, Masanobu
Publication type:
Article
Clinical and virological features of acute hepatitis E in Gunma prefecture, Japan between 2004 and 2015.
Published in:
Hepatology Research, 2017, v. 47, n. 5, p. 435, doi. 10.1111/hepr.12765
By:
- Yamazaki, Yuichi;
- Naganuma, Atsushi;
- Arai, Yosuke;
- Takeuchi, Suguru;
- Kobayashi, Takeshi;
- Takakusagi, Satoshi;
- Hatanaka, Takeshi;
- Hoshino, Takashi;
- Namikawa, Masashi;
- Hashizume, Hiroaki;
- Takizawa, Daichi;
- Ohyama, Tatsuya;
- Suzuki, Hideyuki;
- Horiguchi, Norio;
- Takagi, Hitoshi;
- Sato, Ken;
- Kakizaki, Satoru;
- Kusano, Motoyasu;
- Nagashima, Shigeo;
- Takahashi, Masaharu
Publication type:
Article
Percutaneous radiofrequency ablation for hepatocellular carcinoma located in the caudate lobe of the liver.
Published in:
Acta Gastro-Enterologica Belgica, 2015, v. 78, n. 3, p. 267
By:
- Takeshi Hatanaka;
- Satoru Kakizaki;
- Suzuki Yuhei;
- Suguru Takeuchi;
- Yasushi Shimada;
- Daichi Takizawa;
- Kenji Katakai;
- Ken Sato;
- Masanobu Yamada
Publication type:
Article
Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.
Published in:
Cancers, 2023, v. 15, n. 17, p. 4348, doi. 10.3390/cancers15174348
By:
- Tanaka, Kazunari;
- Tsuji, Kunihiko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article
Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy.
Published in:
Cancers, 2023, v. 15, n. 6, p. 1798, doi. 10.3390/cancers15061798
By:
- Hatanaka, Takeshi;
- Yata, Yutaka;
- Naganuma, Atsushi;
- Kakizaki, Satoru
Publication type:
Article
Relationship between Being Overweight and Clinical Outcomes of Ablation Therapy for Hepatocellular Carcinoma under Ultrasound Guidance: A Retrospective Analysis.
Published in:
Cancers, 2023, v. 15, n. 4, p. 1289, doi. 10.3390/cancers15041289
By:
- Hatanaka, Takeshi;
- Yata, Yutaka;
- Saito, Naoto;
- Nakano, Sachi;
- Nakano, Yuya;
- Hazama, Yoichi;
- Yoshida, Sachiko;
- Hachisu, Yoko;
- Tanaka, Yoshiki;
- Yoshinaga, Teruo;
- Naganuma, Atsushi;
- Kakizaki, Satoru
Publication type:
Article
Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score (mALF Score) for Predicting the Prognosis of Hepatocellular Carcinoma after Hepatectomy.
Published in:
Cancers, 2022, v. 14, n. 21, p. 5292, doi. 10.3390/cancers14215292
By:
- Kaibori, Masaki;
- Yoshii, Kengo;
- Matsui, Kosuke;
- Matsushima, Hideyuki;
- Kosaka, Hisashi;
- Yamamoto, Hidekazu;
- Aoi, Kazunori;
- Yamaguchi, Takashi;
- Yoshida, Katsunori;
- Hatanaka, Takeshi;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Kumada, Takashi;
- Sekimoto, Mitsugu
Publication type:
Article
Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib: Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression Treatment.
Published in:
Cancers, 2020, v. 12, n. 10, p. 2906, doi. 10.3390/cancers12102906
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Nagashima, Tamon;
- Namikawa, Masashi;
- Ueno, Takashi;
- Tojima, Hiroki;
- Takizawa, Daichi;
- Naganuma, Atsushi;
- Arai, Hirotaka;
- Sato, Ken;
- Harimoto, Norifumi;
- Shirabe, Ken;
- Uraoka, Toshio
Publication type:
Article
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate‐stage hepatocellular carcinoma.
Published in:
Liver International, 2024, v. 44, n. 1, p. 113, doi. 10.1111/liv.15753
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 565, doi. 10.1159/000530078
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Kariyama, Kazuya;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Naganuma, Atsushi;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Ohama, Hideko;
- Tada, Fujimasa;
- Nouso, Kazuhiro
Publication type:
Article
Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach.
Published in:
Cancer Medicine, 2023, v. 12, n. 24, p. 21680, doi. 10.1002/cam4.6726
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Yokohama, Keisuke;
- Nishikawa, Hiroki
Publication type:
Article
Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab.
Published in:
Cancer Medicine, 2023, v. 12, n. 17, p. 17849, doi. 10.1002/cam4.6416
By:
- Nouso, Kazuhiro;
- Shiota, Shohei;
- Fujita, Rio;
- Wakuta, Akiko;
- Kariyama, Kazuya;
- Hiraoka, Atsushi;
- Atsukawa, Masanori;
- Tani, Joji;
- Tada, Toshifumi;
- Nakamura, Shinichiro;
- Tajiri, Kazuto;
- Kaibori, Masaki;
- Hirooka, Masashi;
- Itobayashi, Ei;
- Kakizaki, Satoru;
- Naganuma, Atsushi;
- Ishikawa, Toru;
- Hatanaka, Takeshi;
- Fukunishi, Shinya;
- Tsuji, Kunihiko
Publication type:
Article
Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Published in:
Cancer Medicine, 2023, v. 12, n. 7, p. 7772, doi. 10.1002/cam4.5535
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study.
Published in:
Cancer Medicine, 2023, v. 12, n. 6, p. 6980, doi. 10.1002/cam4.5495
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Kariyama, Kazuya;
- Tani, Joji;
- Hirooka, Masashi;
- Takaguchi, Koichi;
- Atsukawa, Masanori;
- Fukunishi, Shinya;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Ishikawa, Toru;
- Yasuda, Satoshi;
- Ogawa, Chikara;
- Toyoda, Hidenori;
- Hatanaka, Takeshi;
- Nishimura, Takashi;
- Kakizaki, Satoru
Publication type:
Article
Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study.
Published in:
Cancer Medicine, 2023, v. 12, n. 5, p. 5293, doi. 10.1002/cam4.5337
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC‐GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis.
Published in:
Cancer Medicine, 2023, v. 12, n. 4, p. 4259, doi. 10.1002/cam4.5294
By:
- Hatanaka, Takeshi;
- Naganuma, Atsushi;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
The prognosis of elderly patients with hepatocellular carcinoma: A multi‐center 19‐year experience in Japan.
Published in:
Cancer Medicine, 2023, v. 12, n. 1, p. 345, doi. 10.1002/cam4.4850
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Kariyama, Kazuya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Toyoda, Hidenori;
- Yasuda, Satoshi;
- Naganuma, Atsushi;
- Tada, Toshifumi;
- Takaguchi, Koichi;
- Tsutsui, Akemi;
- Itobayashi, Ei;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Tanaka, Takaaki;
- Nagano, Takuya;
- Imai, Michitaka;
- Nakamura, Shinichiro;
- Nouso, Kazuhiro
Publication type:
Article
Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib.
Published in:
Cancer Medicine, 2023, v. 12, n. 1, p. 325, doi. 10.1002/cam4.4854
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis.
Published in:
Cancer Medicine, 2022, v. 11, n. 20, p. 3796, doi. 10.1002/cam4.4763
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct‐acting antiviral agents.
Published in:
Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 7, p. 1394, doi. 10.1111/jgh.16553
By:
- Ohama, Hideko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Toyoda, Hidenori;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Naganuma, Atsushi;
- Tada, Fujimasa;
- Tanaka, Hironori;
- Nakamura, Shinichiro;
- Nouso, Kazuhiro;
- Tanaka, Kazunari;
- Kumada, Takashi
Publication type:
Article
Impact of first‐line systemic therapy with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.
Published in:
Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 8, p. 1389, doi. 10.1111/jgh.16225
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab.
Published in:
2022
By:
- Saito, Naoto;
- Hatanaka, Takeshi;
- Nakano, Sachi;
- Hazama, Yoichi;
- Yoshida, Sachiko;
- Hachisu, Yoko;
- Tanaka, Yoshiki;
- Yoshinaga, Teruo;
- Kashiwabara, Kenji;
- Kubo, Norio;
- Hosouchi, Yasuo;
- Tojima, Hiroki;
- Kakizaki, Satoru;
- Uraoka, Toshio
Publication type:
Case Study
Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy.
Published in:
PLoS ONE, 2024, v. 19, n. 9, p. 1, doi. 10.1371/journal.pone.0311084
By:
- Saeki, Issei;
- Shimose, Shigeo;
- Tomonari, Tetsu;
- Ito, Takanori;
- Tani, Joji;
- Takeuchi, Yasuto;
- Yoshioka, Naoki;
- Naito, Takehito;
- Takeuchi, Mamiko;
- Kakizaki, Satoru;
- Hatanaka, Takeshi;
- Sasaki, Kyo;
- Yasunaka, Tetsuya;
- Sakata, Masahiro;
- Iwamoto, Hideki;
- Itano, Satoshi;
- Shirono, Tomotake;
- Tanabe, Norikazu;
- Yamamoto, Takafumi;
- Kanayama, Yuki
Publication type:
Article
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial.
Published in:
2019
By:
- Kondo, Masaaki;
- Morimoto, Manabu;
- Kobayashi, Satoshi;
- Ohkawa, Shinichi;
- Hidaka, Hisashi;
- Nakazawa, Takahide;
- Aikata, Hiroshi;
- Hatanaka, Takeshi;
- Takizawa, Daichi;
- Matsunaga, Kotaro;
- Okuse, Chiaki;
- Suzuki, Michihiro;
- Taguri, Masataka;
- Ishibashi, Takako;
- Numata, Kazushi;
- Maeda, Shin;
- Tanaka, Katsuaki
Publication type:
journal article
Successful Treatment of Pancreatic Fistula Following Surgery for Congenital Biliary Dilatation with Endoscopic Ultrasound-Guided Transduodenal Drainage.
Published in:
2022
By:
- Suzuki, Shigemasa;
- Kubo, Norio;
- Hosoi, Nobuhiro;
- Ooki, Takashi;
- Matsumura, Naoki;
- Aihara, Ryusuke;
- Mogi, Akira;
- Hosouchi, Yasuo;
- Nishida, Yasuji;
- Hatanaka, Takeshi;
- Tanaka, Yoshiki;
- Saeki, Hiroshi;
- Shirabe, Ken
Publication type:
Case Study
Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices.
Published in:
Journal of Gastroenterology, 2023, v. 58, n. 11, p. 1134, doi. 10.1007/s00535-023-02026-2
By:
- Tada, Fujimasa;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article

Found: 66